1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
Olaparib tablets are redefining the landscape of targeted cancer therapy, offering precision-based solutions for healthcare providers and payers focused on optimizing patient outcomes and cost-effectiveness in oncology. Executive stakeholders now face an evolving market shaped by clinical innovation, regulatory shifts, real-world data, global supply-chain complexities, and region-specific dynamics.
Market Snapshot: Olaparib Tablet Market Overview
The global Olaparib tablet market is witnessing robust momentum, underpinned by the expansion of approved indications and the rising adoption of biomarker-driven treatment protocols. Market growth is further bolstered by the integration of genomic profiling into standard care pathways and the emergence of value-based contracts between manufacturers, payers, and providers. This creates a dynamic environment that demands strategic agility from both industry leaders and market entrants.
Scope & Segmentation
This report offers in-depth coverage of the Olaparib tablet market, providing valuable segmentation and contextual analysis to inform investment and operational decisions across major regions and care environments.
- Indication Segments: Breast cancer (BRCA-mutated and non-BRCA), ovarian cancer (BRCA-mutated and non-BRCA), pancreatic cancer, prostate cancer
- Line of Therapy: First line, maintenance (therapy duration above or below six months), second line
- Distribution Channels: Hospital pharmacy (private and public), retail pharmacy (chain and independent), online pharmacy (direct-to-patient, third-party platforms)
- Dosage Strengths: 100 mg (28-tablet and 7-tablet packs), 150 mg (28-tablet and 7-tablet packs)
- Regional Analysis: Americas (United States: California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada, Mexico, Brazil, Argentina), Europe Middle East & Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
Key technologies covered include genomic diagnostic platforms, electronic health record integration, and telehealth tools for therapy monitoring and patient engagement.
Key Takeaways for Strategic Decision-Makers
- Olaparib tablets are increasingly positioned as a core component of personalized oncology, with their utility expanding beyond initial BRCA-mutated ovarian cancer to breast, pancreatic, and prostate cancers.
- Routine genomic screening now informs patient eligibility, accelerating the adoption of PARP inhibitors and enabling earlier therapy initiation.
- Real-world evidence and post-marketing studies are influencing both regulatory labeling and reimbursement criteria, supporting value-based healthcare models.
- Distribution strategy is pivotal, as a blend of hospital, retail, and online pharmacy models meets evolving patient access demands and aligns with regional buying behaviors.
- Innovative patient support and adherence tools, such as integrated health apps and telemedicine consultations, are setting new expectations for therapy optimization and ongoing patient engagement.
Tariff Impact: Navigating Cost Pressures and Supply Chain Complexity
The upcoming 2025 United States tariffs on key pharmaceutical inputs are expected to add volatility to Olaparib tablet supply chains. Manufacturers may experience increased raw material costs, necessitating strategic sourcing approaches and closer supplier collaboration. Relocating certain manufacturing operations and adopting continuous processing technologies offer potential mitigation, but require careful regulatory alignment and capital investment. Transparent cost communication with payers and providers is critical in supporting any product price restructuring as a result of these tariff changes.
Methodology & Data Sources for Olaparib Tablet Market Research
This analysis employs both primary and secondary research, including expert interviews with oncologists, regulators, and supply-chain executives. Data triangulation ensures that findings are cross-checked using public health statistics, proprietary datasets, and consultation with advisory boards. Peer-reviewed publications, clinical trial data, and industry policy documents underlie the evidence-based recommendations provided.
Why This Report Matters
- Enables senior leaders to anticipate clinical and regulatory trends impacting therapy adoption and reimbursement.
- Supports strategic supply-chain decisions and risk management in the context of evolving global trade dynamics.
- Delivers actionable segmentation and regional intelligence to inform investment and go-to-market decisions in the Olaparib tablet market.
Conclusion
The Olaparib tablet landscape is being shaped by clinical innovation, supply chain evolution, and tailored strategies for diverse regional markets. This report arms stakeholders with the insights needed to adapt, capture opportunity, and advance patient-centric oncology solutions.
This product will be delivered within 1-3 business days.
Table of Contents
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of olaparib indication into early-stage breast cancer based on recent clinical trial results
5.2. Strategic partnerships between pharmaceutical companies and diagnostic firms for companion biomarker testing in olaparib therapy
5.3. Market entry of generic olaparib tablets expected to disrupt pricing and reimbursement dynamics globally
5.4. Increasing use of olaparib in combination with immunotherapy regimens to enhance efficacy in ovarian cancer treatment
5.5. Implementation of patient assistance and reimbursement programs to broaden olaparib access in emerging economies
5.6. Regulatory approvals for maintenance olaparib therapy in pancreatic cancer driving new treatment protocols
5.2. Strategic partnerships between pharmaceutical companies and diagnostic firms for companion biomarker testing in olaparib therapy
5.3. Market entry of generic olaparib tablets expected to disrupt pricing and reimbursement dynamics globally
5.4. Increasing use of olaparib in combination with immunotherapy regimens to enhance efficacy in ovarian cancer treatment
5.5. Implementation of patient assistance and reimbursement programs to broaden olaparib access in emerging economies
5.6. Regulatory approvals for maintenance olaparib therapy in pancreatic cancer driving new treatment protocols
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
6.2. PESTLE Analysis
8. Olaparib Tablets Market, by Indication
8.1. Introduction
8.2. Breast Cancer
8.2.1. BRCA Mutated
8.2.2. Non-BRCA Mutated
8.3. Ovarian Cancer
8.3.1. BRCA Mutated
8.3.2. Non-BRCA Mutated
8.4. Pancreatic Cancer
8.5. Prostate Cancer
8.2. Breast Cancer
8.2.1. BRCA Mutated
8.2.2. Non-BRCA Mutated
8.3. Ovarian Cancer
8.3.1. BRCA Mutated
8.3.2. Non-BRCA Mutated
8.4. Pancreatic Cancer
8.5. Prostate Cancer
9. Olaparib Tablets Market, by Line Of Therapy
9.1. Introduction
9.2. First Line
9.3. Maintenance
9.3.1. Duration Of Therapy >6 Months
9.3.2. Duration Of Therapy =6 Months
9.4. Second Line
9.2. First Line
9.3. Maintenance
9.3.1. Duration Of Therapy >6 Months
9.3.2. Duration Of Therapy =6 Months
9.4. Second Line
10. Olaparib Tablets Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacy
10.2.1. Private Hospital
10.2.2. Public Hospital
10.3. Online Pharmacy
10.3.1. Direct To Patient
10.3.2. Third Party Platform
10.4. Retail Pharmacy
10.4.1. Chain Pharmacy
10.4.2. Independent Pharmacy
10.2. Hospital Pharmacy
10.2.1. Private Hospital
10.2.2. Public Hospital
10.3. Online Pharmacy
10.3.1. Direct To Patient
10.3.2. Third Party Platform
10.4. Retail Pharmacy
10.4.1. Chain Pharmacy
10.4.2. Independent Pharmacy
11. Olaparib Tablets Market, by Dosage Strength
11.1. Introduction
11.2. 100 Mg
11.2.1. 28 Tablet Pack
11.2.2. 7 Tablet Pack
11.3. 150 Mg
11.3.1. 28 Tablet Pack
11.3.2. 7 Tablet Pack
11.2. 100 Mg
11.2.1. 28 Tablet Pack
11.2.2. 7 Tablet Pack
11.3. 150 Mg
11.3.1. 28 Tablet Pack
11.3.2. 7 Tablet Pack
12. Americas Olaparib Tablets Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Olaparib Tablets Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Olaparib Tablets Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. AstraZeneca plc
15.3.2. Merck & Co., Inc.
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. AstraZeneca plc
15.3.2. Merck & Co., Inc.
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. OLAPARIB TABLETS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL OLAPARIB TABLETS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY LINE OF THERAPY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY LINE OF THERAPY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2030 (%)
FIGURE 12. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC OLAPARIB TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC OLAPARIB TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. OLAPARIB TABLETS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. OLAPARIB TABLETS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. OLAPARIB TABLETS MARKET: RESEARCHAI
FIGURE 24. OLAPARIB TABLETS MARKET: RESEARCHSTATISTICS
FIGURE 25. OLAPARIB TABLETS MARKET: RESEARCHCONTACTS
FIGURE 26. OLAPARIB TABLETS MARKET: RESEARCHARTICLES
FIGURE 2. GLOBAL OLAPARIB TABLETS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY LINE OF THERAPY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY LINE OF THERAPY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2030 (%)
FIGURE 12. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC OLAPARIB TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC OLAPARIB TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. OLAPARIB TABLETS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. OLAPARIB TABLETS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. OLAPARIB TABLETS MARKET: RESEARCHAI
FIGURE 24. OLAPARIB TABLETS MARKET: RESEARCHSTATISTICS
FIGURE 25. OLAPARIB TABLETS MARKET: RESEARCHCONTACTS
FIGURE 26. OLAPARIB TABLETS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. OLAPARIB TABLETS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL OLAPARIB TABLETS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL OLAPARIB TABLETS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY BREAST CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY BRCA MUTATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY BRCA MUTATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY NON-BRCA MUTATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY NON-BRCA MUTATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY BREAST CANCER, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY BREAST CANCER, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY OVARIAN CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY OVARIAN CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY BRCA MUTATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY BRCA MUTATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY NON-BRCA MUTATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY NON-BRCA MUTATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY OVARIAN CANCER, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY OVARIAN CANCER, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY PANCREATIC CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY PANCREATIC CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY FIRST LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY FIRST LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY MAINTENANCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY MAINTENANCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY DURATION OF THERAPY >6 MONTHS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY DURATION OF THERAPY >6 MONTHS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY DURATION OF THERAPY =6 MONTHS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY DURATION OF THERAPY =6 MONTHS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY MAINTENANCE, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY MAINTENANCE, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY SECOND LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY SECOND LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY DIRECT TO PATIENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY DIRECT TO PATIENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY THIRD PARTY PLATFORM, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY THIRD PARTY PLATFORM, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY 100 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY 100 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY 28 TABLET PACK, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY 28 TABLET PACK, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY 7 TABLET PACK, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY 7 TABLET PACK, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY 100 MG, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY 100 MG, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY 150 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY 150 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY 28 TABLET PACK, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY 28 TABLET PACK, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY 7 TABLET PACK, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY 7 TABLET PACK, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY 150 MG, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY 150 MG, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY BREAST CANCER, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY BREAST CANCER, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY OVARIAN CANCER, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY OVARIAN CANCER, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY MAINTENANCE, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY MAINTENANCE, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY 100 MG, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY 100 MG, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY 150 MG, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY 150 MG, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY BREAST CANCER, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY BREAST CANCER, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY OVARIAN CANCER, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY OVARIAN CANCER, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY MAINTENANCE, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY MAINTENANCE, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY 100 MG, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY 100 MG, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY 150 MG, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY 150 MG, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 141. CANADA OLAPARIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 142. CANADA OLAPARIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 143. CANADA OLAPARIB TABLETS MARKET SIZE, BY BREAST CANCER, 2018-2024 (USD MILLION)
TABLE 144. CANADA OLAPARIB TABLETS MARKET SIZE, BY BREAST CANCER, 2025-2030 (USD MILLION)
TABLE 145. CANADA OLAPARIB TABLETS MARKET SIZE, BY OVARIAN CANCER, 2018-2024 (USD MILLION)
TABLE 146. CANADA OLAPARIB TABLETS MARKET SIZE, BY OVARIAN CANCER, 2025-2030 (USD MILLION)
TABLE 147. CANADA OLAPARIB TABLETS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 148. CANADA OLAPARIB TABLETS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 149. CANADA OLAPARIB TABLETS MARKET SIZE, BY MAINTENANCE, 2018-2024 (USD MILLION)
TABLE 150. CANADA OLAPARIB TABLETS MARKET SIZE, BY MAINTENANCE, 2025-2030 (USD MILLION)
TABLE 151. CANADA OLAPARIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 152. CANADA OLAPARIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 153. CANADA OLAPARIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 154. CANADA OLAPARIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 155. CANADA OLAPARIB TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 156. CANADA OLAPARIB TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 157. CANADA OLAPARIB TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 158. CANADA OLAPARIB TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 159. CANADA OLAPARIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 160. CANADA OLAPARIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 161. CANADA OLAPARIB TABLETS MARKET SIZE, BY 100 MG, 2018-2024 (USD MILLION)
TABLE 162. CANADA OLAPARIB TABLETS MARKET SIZE, BY 100 MG, 2025-2030 (USD MILLION)
TABLE 163. CANADA OLAPARIB TABLETS MARKET SIZE, BY 150 MG, 2018-2024 (USD MILLION)
TABLE 164. CANADA OLAPARIB TABLETS MARKET SIZE, BY 150 MG, 2025-2030 (USD MILLION)
TABLE 165. MEXICO OLAPARIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 166. MEXICO OLAPARIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 167. MEXICO OLAPARIB TABLETS MARKET SIZE, BY BREAST CANCER, 2018-2024 (USD MILLION)
TABLE 168. MEXICO OLAPARIB TABLETS MARKET SIZE, BY BREAST CANCER, 2025-2030 (USD MILLION)
TABLE 169. MEXICO OLAPARIB TABLETS MARKET SIZE, BY OVARIAN CANCER, 2018-2024 (USD MILLION)
TABLE 170. MEXICO OLAPARIB TABLETS MARKET SIZE, BY OVARIAN CANCER, 2025-2030 (USD MILLION)
TABLE 171. MEXICO OLAPARIB TABLETS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 172. MEXICO OLAPARIB TABLETS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 173. MEXICO OLAPARIB TABLETS MARKET SIZE, BY MAINTENANCE, 2018-2024 (USD MILLION)
TABLE 174. MEXICO OLAPARIB TABLETS MARKET SIZE, BY MAINTENANCE, 2025-2030 (USD MILLION)
TABLE 175. MEXICO OLAPARIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 176. MEXICO OLAPARIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 177. MEXICO OLAPARIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 178. MEXICO OLAPARIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 179. MEXICO OLAPARIB TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 180. MEXICO OLAPARIB TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 181. MEXICO OLAPARIB TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 182. MEXICO OLAPARIB TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 183. MEXICO OLAPARIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 184. MEXICO OLAPARIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 185. MEXICO OLAPARIB TABLETS MARKET SIZE, BY 100 MG, 2018-2024 (USD MILLION)
TABLE 186. MEXICO OLAPARIB TABLETS MARKET SIZE, BY 100 MG, 2025-2030 (USD MILLION)
TABLE 187. MEXICO OLAPARIB TABLETS MARKET SIZE, BY 150 MG, 2018-2024 (USD MILLION)
TABLE 188. MEXICO OLAPARIB TABLETS MARKET SIZE, BY 150 MG, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL OLAPARIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL OLAPARIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL OLAPARIB TABLETS MARKET SIZE, BY BREAST CANCER, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL OLAPARIB TABLETS MARKET SIZE, BY BREAST CANCER, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL OLAPARIB TABLETS MARKET SIZE, BY OVARIAN CANCER, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL OLAPARIB TABLETS MARKET SIZE, BY OVARIAN CANCER, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL OLAPARIB TABLETS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL OLAPARIB TABLETS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL OLAPARIB TABLETS MARKET SIZE, BY MAINTENANCE, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL OLAPARIB TABLETS MARKET SIZE, BY MAINTENANCE, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL OLAPARIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL OLAPARIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL OLAPARIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL OLAPARIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL OLAPARIB TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL OLAPARIB TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL OLAPARIB TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL OLAPARIB TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL OLAPARIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL OLAPARIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL OLAPARIB TABLETS MARKET SIZE, BY 100 MG, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL OLAPARIB TABLETS MARKET SIZE, BY 100 MG, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL OLAPARIB TABLETS MARKET SIZE, BY 150 MG, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL OLAPARIB TABLETS MARKET SIZE, BY 150 MG, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA OLAPARIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA OLAPARIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA OLAPARIB TABLETS MARKET SIZE, BY BREAST CANCER, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA OLAPARIB TABLETS MARKET SIZE, BY BREAST CANCER, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA OLAPARIB TABLETS MARKET SIZE, BY OVARIAN CANCER, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA OLAPARIB TABLETS MARKET SIZE, BY OVARIAN CANCER, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA OLAPARIB TABLETS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA OLAPARIB TABLETS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA OLAPARIB TABLETS MARKET SIZE, BY MAINTENANCE, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA OLAPARIB TABLETS MARKET SIZE, BY MAINTENANCE, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA OLAPARIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA OLAPARIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA OLAPARIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA OLAPARIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA OLAPARIB TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA OLAPARIB TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA OLAPARIB TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA OLAPARIB TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA OLAPARIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA OLAPARIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA OLAPARIB TABLETS MARKET SIZE, BY 100 MG, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA OLAPARIB TABLETS MARKET SIZE, BY 100 MG, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA OLAPARIB TABLETS MARKET SIZE, BY 150 MG, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA OLAPARIB TABLETS MARKET SIZE, BY 150 MG, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY BREAST CANCER, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY BREAST CANCER, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY OVARIAN CANCER, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY OVARIAN CANCER, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY MAINTENANCE, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY MAINTENANCE, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY 100 MG, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY 100 MG, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY 150 MG, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY 150 MG, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM OLAPARIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM OLAPARIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM OLAPARIB TABLETS MARKET SIZE, BY BREAST CANCER, 2018-2024 (USD MILLION)
TABLE 266. UNITED KINGDOM OLAPARIB TABLETS MARKET SIZE, BY BREAST CANCER, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM OLAPARIB TABLETS MARKET SIZE, BY OVARIAN CANCER, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM OLAPARIB TABLETS MARKET SIZE, BY OVARIAN CANCER, 2025-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM OLAPARIB TABLETS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 270. UNITED KINGDOM OLAPARIB TABLETS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM OLAPARIB TABLETS MARKET SIZE, BY MAINTENANCE, 2018-2024 (USD MILLION)
TABLE 272. UNITED KINGDOM OLAPARIB TABLETS MARKET SIZE, BY MAINTENANCE, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM OLAPARIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM OLAPARIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM OLAPARIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 276. UNITED KINGDOM OLAPARIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM OLAPARIB TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 278. UNITED KINGDOM OLAPARIB TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM OLAPARIB TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 280. UNITED KINGDOM OLAPARIB TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM OLAPARIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 282. UNITED KINGDOM OLAPARIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM OLAPARIB TABLETS MARKET SIZE, BY 100 MG, 2018-2024 (USD MILLION)
TABLE 284. UNITED KINGDOM OLAPARIB TABLETS MARKET SIZE, BY 100 MG, 2025-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM OLAPARIB TABLETS MARKET SIZE, BY 150 MG, 2018-2024 (USD MILLION)
TABLE 286. UNITED KINGDOM OLAPARIB TABLETS MARKET SIZE, BY 150 MG, 2025-2030 (USD MILLION)
TABLE 287. GERMANY OLAPARIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 288. GERMANY OLAPARIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 289. GERMANY OLAPARIB TABLETS MARKET SIZE, BY BREAST CANCER, 2018-2024 (USD MILLION)
TABLE 290. GERMANY OLAPARIB TABLETS MARKET SIZE, BY BREAST CANCER, 2025-2030 (USD MILLION)
TABLE 291. GERMANY OLAPARIB TABLETS MARKET SIZE, BY OVARIAN CANCER, 2018-2024 (USD MILLION)
TABLE 292. GERMANY OLAPARIB TABLETS MARKET SIZE, BY OVARIAN CANCER, 2025-2030 (USD MILLION)
TABLE 293. GERMANY OLAPARIB TABLETS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 294. GERMANY OLAPARIB TABLETS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 295. GERMANY OLAPARIB TABLETS MARKET SIZE, BY MAINTENANCE, 2018-2024 (USD MILLION)
TABLE 296. GERMANY OLAPARIB TABLETS MARKET SIZE, BY MAINTENANCE, 2025-2030 (USD MILLION)
TABLE 297. GERMANY OLAPARIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 298. GERMANY OLAPARIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 299. GERMANY OLAPARIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 300. GERMANY OLAPARIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 301. GERMANY OLAPARIB TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 302. GERMANY OLAPARIB TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 303. GERMANY OLAPARIB TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 304. GERMANY OLAPARIB TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 305. GERMANY OLAPARIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 306. GERMANY OLAPARIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 307. GERMANY OLAPARIB TABLETS MARKET SIZE, BY 100 MG, 2018-2024 (USD MILLION)
TABLE 308. GERMANY OLAPARIB TABLETS MARKET SIZE, BY 100 MG, 2025-2030 (USD MILLION)
TABLE 309. GERMANY OLAPARIB TABLETS MARKET SIZE, BY 150 MG, 2018-2024 (USD MILLION)
TABLE 310. GERMANY OLAPARIB TABLETS MARKET SIZE, BY 150 MG, 2025-2030 (USD MILLION)
TABLE 311. FRANCE OLAPARIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 312. FRANCE OLAPARIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 313. FRANCE OLAPARIB TABLETS MARKET SIZE, BY BREAST CANCER, 2018-2024 (USD MILLION)
TABLE 314. FRANCE OLAPARIB TABLETS MARKET SIZE, BY BREAST CANCER, 2025-2030 (USD MILLION)
TABLE 315. FRANCE OLAPARIB TABLETS MARKET SIZE, BY OVARIAN CANCER, 2018-2024 (USD MILLION)
TABLE 316. FRANCE OLAPARIB TABLETS MARKET SIZE, BY OVARIAN CANCER, 2025-2030 (USD MILLION)
TABLE 317. FRANCE OLAPARIB TABLETS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 318. FRANCE OLAPARIB TABLETS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 319. FRANCE OLAPARIB TABLETS MARKET SIZE, BY MAINTENANCE, 2018-2024 (USD MILLION)
TABLE 320. FRANCE OLAPARIB TABLETS MARKET SIZE, BY MAINTENANCE, 2025-2030 (USD MILLION)
TABLE 321. FRANCE OLAPARIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 322. FRANCE OLAPARIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 323. FRANCE OLAPARIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 324. FRANCE OLAPARIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 325. FRANCE OLAPARIB TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 326. FRANCE OLAPARIB TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 327. FRANCE OLAPARIB TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 328. FRANCE OLAPARIB TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 329. FRANCE OLAPARIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 330. FRANCE OLAPARIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 331. FRANCE OLAPARIB TABLETS MARKET SIZE, BY 100 MG, 2018-2024 (USD MILLION)
TABLE 332. FRANCE OLAPARIB TABLETS MARKET SIZE, BY 100 MG, 2025-2030 (USD MILLION)
TABLE 333. FRANCE OLAPARIB TABLETS MARKET SIZE, BY 150 MG, 2018-2024 (USD MILLION)
TABLE 334. FRANCE OLAPARIB TABLETS MARKET SIZE, BY 150 MG, 2025-2030 (USD MILLION)
TABLE 335. RUSSIA OLAPARIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 336. RUSSIA OLAPARIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 337. RUSSIA OLAPARIB TABLETS MARKET SIZE, BY BREAST CANCER, 2018-2024 (USD MILLION)
TABLE 338. RUSSIA OLAPARIB TABLETS MARKET SIZE, BY BREAST CANCER, 2025-2030 (USD MILLION)
TABLE 339. RUSSIA OLAPARIB TABLETS MARKET SIZE, BY OVARIAN CANCER, 2018-2024 (USD MILLION)
TABLE 340. RUSSIA OLAPARIB TABLETS MARKET SIZE, BY OVARIAN CANCER, 2025-2030 (USD MILLION)
TABLE 341. RUSSIA OLAPARIB TABLETS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 342. RUSSIA OLAPARIB TABLETS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 343. RUSSIA OLAPARIB TABLETS MARKET SIZE, BY MAINTENANCE, 2018-2024 (USD MILLION)
TABLE 344. RUSSIA OLAPARIB TABLETS MARKET SIZE, BY MAINTENANCE, 2025-2030 (USD MILLION)
TABLE 345. RUSSIA OLAPARIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 346. RUSSIA OLAPARIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 347. RUSSIA OLAPARIB TABLETS MARKET SIZ
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL OLAPARIB TABLETS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL OLAPARIB TABLETS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY BREAST CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY BRCA MUTATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY BRCA MUTATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY NON-BRCA MUTATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY NON-BRCA MUTATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY BREAST CANCER, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY BREAST CANCER, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY OVARIAN CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY OVARIAN CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY BRCA MUTATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY BRCA MUTATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY NON-BRCA MUTATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY NON-BRCA MUTATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY OVARIAN CANCER, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY OVARIAN CANCER, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY PANCREATIC CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY PANCREATIC CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY FIRST LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY FIRST LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY MAINTENANCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY MAINTENANCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY DURATION OF THERAPY >6 MONTHS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY DURATION OF THERAPY >6 MONTHS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY DURATION OF THERAPY =6 MONTHS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY DURATION OF THERAPY =6 MONTHS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY MAINTENANCE, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY MAINTENANCE, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY SECOND LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY SECOND LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY DIRECT TO PATIENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY DIRECT TO PATIENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY THIRD PARTY PLATFORM, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY THIRD PARTY PLATFORM, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY 100 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY 100 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY 28 TABLET PACK, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY 28 TABLET PACK, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY 7 TABLET PACK, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY 7 TABLET PACK, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY 100 MG, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY 100 MG, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY 150 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY 150 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY 28 TABLET PACK, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY 28 TABLET PACK, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY 7 TABLET PACK, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY 7 TABLET PACK, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY 150 MG, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL OLAPARIB TABLETS MARKET SIZE, BY 150 MG, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY BREAST CANCER, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY BREAST CANCER, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY OVARIAN CANCER, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY OVARIAN CANCER, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY MAINTENANCE, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY MAINTENANCE, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY 100 MG, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY 100 MG, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY 150 MG, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY 150 MG, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS OLAPARIB TABLETS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY BREAST CANCER, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY BREAST CANCER, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY OVARIAN CANCER, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY OVARIAN CANCER, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY MAINTENANCE, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY MAINTENANCE, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY 100 MG, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY 100 MG, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY 150 MG, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY 150 MG, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES OLAPARIB TABLETS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 141. CANADA OLAPARIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 142. CANADA OLAPARIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 143. CANADA OLAPARIB TABLETS MARKET SIZE, BY BREAST CANCER, 2018-2024 (USD MILLION)
TABLE 144. CANADA OLAPARIB TABLETS MARKET SIZE, BY BREAST CANCER, 2025-2030 (USD MILLION)
TABLE 145. CANADA OLAPARIB TABLETS MARKET SIZE, BY OVARIAN CANCER, 2018-2024 (USD MILLION)
TABLE 146. CANADA OLAPARIB TABLETS MARKET SIZE, BY OVARIAN CANCER, 2025-2030 (USD MILLION)
TABLE 147. CANADA OLAPARIB TABLETS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 148. CANADA OLAPARIB TABLETS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 149. CANADA OLAPARIB TABLETS MARKET SIZE, BY MAINTENANCE, 2018-2024 (USD MILLION)
TABLE 150. CANADA OLAPARIB TABLETS MARKET SIZE, BY MAINTENANCE, 2025-2030 (USD MILLION)
TABLE 151. CANADA OLAPARIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 152. CANADA OLAPARIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 153. CANADA OLAPARIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 154. CANADA OLAPARIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 155. CANADA OLAPARIB TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 156. CANADA OLAPARIB TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 157. CANADA OLAPARIB TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 158. CANADA OLAPARIB TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 159. CANADA OLAPARIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 160. CANADA OLAPARIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 161. CANADA OLAPARIB TABLETS MARKET SIZE, BY 100 MG, 2018-2024 (USD MILLION)
TABLE 162. CANADA OLAPARIB TABLETS MARKET SIZE, BY 100 MG, 2025-2030 (USD MILLION)
TABLE 163. CANADA OLAPARIB TABLETS MARKET SIZE, BY 150 MG, 2018-2024 (USD MILLION)
TABLE 164. CANADA OLAPARIB TABLETS MARKET SIZE, BY 150 MG, 2025-2030 (USD MILLION)
TABLE 165. MEXICO OLAPARIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 166. MEXICO OLAPARIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 167. MEXICO OLAPARIB TABLETS MARKET SIZE, BY BREAST CANCER, 2018-2024 (USD MILLION)
TABLE 168. MEXICO OLAPARIB TABLETS MARKET SIZE, BY BREAST CANCER, 2025-2030 (USD MILLION)
TABLE 169. MEXICO OLAPARIB TABLETS MARKET SIZE, BY OVARIAN CANCER, 2018-2024 (USD MILLION)
TABLE 170. MEXICO OLAPARIB TABLETS MARKET SIZE, BY OVARIAN CANCER, 2025-2030 (USD MILLION)
TABLE 171. MEXICO OLAPARIB TABLETS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 172. MEXICO OLAPARIB TABLETS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 173. MEXICO OLAPARIB TABLETS MARKET SIZE, BY MAINTENANCE, 2018-2024 (USD MILLION)
TABLE 174. MEXICO OLAPARIB TABLETS MARKET SIZE, BY MAINTENANCE, 2025-2030 (USD MILLION)
TABLE 175. MEXICO OLAPARIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 176. MEXICO OLAPARIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 177. MEXICO OLAPARIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 178. MEXICO OLAPARIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 179. MEXICO OLAPARIB TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 180. MEXICO OLAPARIB TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 181. MEXICO OLAPARIB TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 182. MEXICO OLAPARIB TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 183. MEXICO OLAPARIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 184. MEXICO OLAPARIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 185. MEXICO OLAPARIB TABLETS MARKET SIZE, BY 100 MG, 2018-2024 (USD MILLION)
TABLE 186. MEXICO OLAPARIB TABLETS MARKET SIZE, BY 100 MG, 2025-2030 (USD MILLION)
TABLE 187. MEXICO OLAPARIB TABLETS MARKET SIZE, BY 150 MG, 2018-2024 (USD MILLION)
TABLE 188. MEXICO OLAPARIB TABLETS MARKET SIZE, BY 150 MG, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL OLAPARIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL OLAPARIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL OLAPARIB TABLETS MARKET SIZE, BY BREAST CANCER, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL OLAPARIB TABLETS MARKET SIZE, BY BREAST CANCER, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL OLAPARIB TABLETS MARKET SIZE, BY OVARIAN CANCER, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL OLAPARIB TABLETS MARKET SIZE, BY OVARIAN CANCER, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL OLAPARIB TABLETS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL OLAPARIB TABLETS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL OLAPARIB TABLETS MARKET SIZE, BY MAINTENANCE, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL OLAPARIB TABLETS MARKET SIZE, BY MAINTENANCE, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL OLAPARIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL OLAPARIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL OLAPARIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL OLAPARIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL OLAPARIB TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL OLAPARIB TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL OLAPARIB TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL OLAPARIB TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL OLAPARIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL OLAPARIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL OLAPARIB TABLETS MARKET SIZE, BY 100 MG, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL OLAPARIB TABLETS MARKET SIZE, BY 100 MG, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL OLAPARIB TABLETS MARKET SIZE, BY 150 MG, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL OLAPARIB TABLETS MARKET SIZE, BY 150 MG, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA OLAPARIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA OLAPARIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA OLAPARIB TABLETS MARKET SIZE, BY BREAST CANCER, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA OLAPARIB TABLETS MARKET SIZE, BY BREAST CANCER, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA OLAPARIB TABLETS MARKET SIZE, BY OVARIAN CANCER, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA OLAPARIB TABLETS MARKET SIZE, BY OVARIAN CANCER, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA OLAPARIB TABLETS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA OLAPARIB TABLETS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA OLAPARIB TABLETS MARKET SIZE, BY MAINTENANCE, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA OLAPARIB TABLETS MARKET SIZE, BY MAINTENANCE, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA OLAPARIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA OLAPARIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA OLAPARIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA OLAPARIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA OLAPARIB TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA OLAPARIB TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA OLAPARIB TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA OLAPARIB TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA OLAPARIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA OLAPARIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA OLAPARIB TABLETS MARKET SIZE, BY 100 MG, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA OLAPARIB TABLETS MARKET SIZE, BY 100 MG, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA OLAPARIB TABLETS MARKET SIZE, BY 150 MG, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA OLAPARIB TABLETS MARKET SIZE, BY 150 MG, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY BREAST CANCER, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY BREAST CANCER, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY OVARIAN CANCER, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY OVARIAN CANCER, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY MAINTENANCE, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY MAINTENANCE, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY 100 MG, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY 100 MG, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY 150 MG, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY 150 MG, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA OLAPARIB TABLETS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM OLAPARIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM OLAPARIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM OLAPARIB TABLETS MARKET SIZE, BY BREAST CANCER, 2018-2024 (USD MILLION)
TABLE 266. UNITED KINGDOM OLAPARIB TABLETS MARKET SIZE, BY BREAST CANCER, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM OLAPARIB TABLETS MARKET SIZE, BY OVARIAN CANCER, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM OLAPARIB TABLETS MARKET SIZE, BY OVARIAN CANCER, 2025-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM OLAPARIB TABLETS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 270. UNITED KINGDOM OLAPARIB TABLETS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM OLAPARIB TABLETS MARKET SIZE, BY MAINTENANCE, 2018-2024 (USD MILLION)
TABLE 272. UNITED KINGDOM OLAPARIB TABLETS MARKET SIZE, BY MAINTENANCE, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM OLAPARIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM OLAPARIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM OLAPARIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 276. UNITED KINGDOM OLAPARIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM OLAPARIB TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 278. UNITED KINGDOM OLAPARIB TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM OLAPARIB TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 280. UNITED KINGDOM OLAPARIB TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM OLAPARIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 282. UNITED KINGDOM OLAPARIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM OLAPARIB TABLETS MARKET SIZE, BY 100 MG, 2018-2024 (USD MILLION)
TABLE 284. UNITED KINGDOM OLAPARIB TABLETS MARKET SIZE, BY 100 MG, 2025-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM OLAPARIB TABLETS MARKET SIZE, BY 150 MG, 2018-2024 (USD MILLION)
TABLE 286. UNITED KINGDOM OLAPARIB TABLETS MARKET SIZE, BY 150 MG, 2025-2030 (USD MILLION)
TABLE 287. GERMANY OLAPARIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 288. GERMANY OLAPARIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 289. GERMANY OLAPARIB TABLETS MARKET SIZE, BY BREAST CANCER, 2018-2024 (USD MILLION)
TABLE 290. GERMANY OLAPARIB TABLETS MARKET SIZE, BY BREAST CANCER, 2025-2030 (USD MILLION)
TABLE 291. GERMANY OLAPARIB TABLETS MARKET SIZE, BY OVARIAN CANCER, 2018-2024 (USD MILLION)
TABLE 292. GERMANY OLAPARIB TABLETS MARKET SIZE, BY OVARIAN CANCER, 2025-2030 (USD MILLION)
TABLE 293. GERMANY OLAPARIB TABLETS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 294. GERMANY OLAPARIB TABLETS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 295. GERMANY OLAPARIB TABLETS MARKET SIZE, BY MAINTENANCE, 2018-2024 (USD MILLION)
TABLE 296. GERMANY OLAPARIB TABLETS MARKET SIZE, BY MAINTENANCE, 2025-2030 (USD MILLION)
TABLE 297. GERMANY OLAPARIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 298. GERMANY OLAPARIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 299. GERMANY OLAPARIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 300. GERMANY OLAPARIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 301. GERMANY OLAPARIB TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 302. GERMANY OLAPARIB TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 303. GERMANY OLAPARIB TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 304. GERMANY OLAPARIB TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 305. GERMANY OLAPARIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 306. GERMANY OLAPARIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 307. GERMANY OLAPARIB TABLETS MARKET SIZE, BY 100 MG, 2018-2024 (USD MILLION)
TABLE 308. GERMANY OLAPARIB TABLETS MARKET SIZE, BY 100 MG, 2025-2030 (USD MILLION)
TABLE 309. GERMANY OLAPARIB TABLETS MARKET SIZE, BY 150 MG, 2018-2024 (USD MILLION)
TABLE 310. GERMANY OLAPARIB TABLETS MARKET SIZE, BY 150 MG, 2025-2030 (USD MILLION)
TABLE 311. FRANCE OLAPARIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 312. FRANCE OLAPARIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 313. FRANCE OLAPARIB TABLETS MARKET SIZE, BY BREAST CANCER, 2018-2024 (USD MILLION)
TABLE 314. FRANCE OLAPARIB TABLETS MARKET SIZE, BY BREAST CANCER, 2025-2030 (USD MILLION)
TABLE 315. FRANCE OLAPARIB TABLETS MARKET SIZE, BY OVARIAN CANCER, 2018-2024 (USD MILLION)
TABLE 316. FRANCE OLAPARIB TABLETS MARKET SIZE, BY OVARIAN CANCER, 2025-2030 (USD MILLION)
TABLE 317. FRANCE OLAPARIB TABLETS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 318. FRANCE OLAPARIB TABLETS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 319. FRANCE OLAPARIB TABLETS MARKET SIZE, BY MAINTENANCE, 2018-2024 (USD MILLION)
TABLE 320. FRANCE OLAPARIB TABLETS MARKET SIZE, BY MAINTENANCE, 2025-2030 (USD MILLION)
TABLE 321. FRANCE OLAPARIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 322. FRANCE OLAPARIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 323. FRANCE OLAPARIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 324. FRANCE OLAPARIB TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 325. FRANCE OLAPARIB TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 326. FRANCE OLAPARIB TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 327. FRANCE OLAPARIB TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 328. FRANCE OLAPARIB TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 329. FRANCE OLAPARIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 330. FRANCE OLAPARIB TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 331. FRANCE OLAPARIB TABLETS MARKET SIZE, BY 100 MG, 2018-2024 (USD MILLION)
TABLE 332. FRANCE OLAPARIB TABLETS MARKET SIZE, BY 100 MG, 2025-2030 (USD MILLION)
TABLE 333. FRANCE OLAPARIB TABLETS MARKET SIZE, BY 150 MG, 2018-2024 (USD MILLION)
TABLE 334. FRANCE OLAPARIB TABLETS MARKET SIZE, BY 150 MG, 2025-2030 (USD MILLION)
TABLE 335. RUSSIA OLAPARIB TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 336. RUSSIA OLAPARIB TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 337. RUSSIA OLAPARIB TABLETS MARKET SIZE, BY BREAST CANCER, 2018-2024 (USD MILLION)
TABLE 338. RUSSIA OLAPARIB TABLETS MARKET SIZE, BY BREAST CANCER, 2025-2030 (USD MILLION)
TABLE 339. RUSSIA OLAPARIB TABLETS MARKET SIZE, BY OVARIAN CANCER, 2018-2024 (USD MILLION)
TABLE 340. RUSSIA OLAPARIB TABLETS MARKET SIZE, BY OVARIAN CANCER, 2025-2030 (USD MILLION)
TABLE 341. RUSSIA OLAPARIB TABLETS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 342. RUSSIA OLAPARIB TABLETS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 343. RUSSIA OLAPARIB TABLETS MARKET SIZE, BY MAINTENANCE, 2018-2024 (USD MILLION)
TABLE 344. RUSSIA OLAPARIB TABLETS MARKET SIZE, BY MAINTENANCE, 2025-2030 (USD MILLION)
TABLE 345. RUSSIA OLAPARIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 346. RUSSIA OLAPARIB TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 347. RUSSIA OLAPARIB TABLETS MARKET SIZ
Samples
LOADING...
Companies Mentioned
The companies profiled in this Olaparib Tablets market report include:- AstraZeneca plc
- Merck & Co., Inc.
